ClinicalTrials.Veeva

Menu
E

Enhancing Care Foundation | Wentworth Hospital

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Islatravir
Doravirine

Parent organization

This site is a part of Enhancing Care Foundation

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

This is a randomized, active-controlled, double-blind clinical study designed to evaluate the antiretroviral activity, safety, and tolerability of do...

Enrolling
HIV-1 Infection
Drug: BIC/FTC/TAF
Drug: Placebo to DOR/ISL

The safety and tolerability of MK-8591A, a 2-drug fixed dose combination (FDC) of doravirine (DOR 100mg) and islatravir (ISL 0.75mg) will be evaluate...

Active, not recruiting
HIV-1 Infection
Drug: MK-8591A

Trial sponsors

Merck Sharp & Dohme (MSD) logo
U
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems